Company / PP&E per Share
Co-Diagnostics, Inc. PP&E per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$2.06
FY2025
5-year range
$0.07 / $2.06
FY2021-FY2025
Trend
+2234.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E per Share changed +2235% YoY in FY2025, a notable deviation from the 8-year average annual change of +318%.
Based on SEC 10-K filings.
2.06 in FY2025 with a 5-year CAGR of +106.6%.
Improved from $0.10 to $2.06 over the past 2 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +201.7%
- 5-Year CAGR
- +106.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, pp&e per share increased 2234.6% year-over-year.
- Lowest pp&e per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.06 | +2234.6% |
| FY2024 | $0.09 | -10.2% |
| FY2023 | $0.10 | +31.0% |
| FY2022 | $0.08 | +10.9% |
| FY2021 | $0.07 | +23.6% |
| FY2020 | $0.05 | +259.5% |
| FY2019 | $0.02 | +20.1% |
| FY2018 | $0.01 | -24.3% |
| FY2017 | $0.02 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026